Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $100M Series A (Sep 2025) at $520M valuation led by Temasek and NEA with NVIDIA. Kemira strategic partnership. 20x contract value growth in 21 months. Materials discovery in 6 months vs. a decade.
CuspAI is building the search engine for materials — an AI platform where researchers input desired material properties and receive novel chemical compositions within days rather than decades of traditional experimental synthesis. The company raised $100 million in Series A financing at a $520 million valuation in September 2025, led by Temasek and NEA with NVIDIA as a strategic co-investor. CuspAI has demonstrated full-cycle materials discovery in 6 months versus the decade-long timelines of traditional research, with contract value growing 20x in 21 months.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.